Keystone Financial Planning Inc. Trims Position in Philip Morris International Inc. $PM

Keystone Financial Planning Inc. decreased its holdings in shares of Philip Morris International Inc. (NYSE:PM) by 28.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,244 shares of the company’s stock after selling 10,114 shares during the period. Philip Morris International makes up approximately 1.2% of Keystone Financial Planning Inc.’s holdings, making the stock its 19th largest position. Keystone Financial Planning Inc.’s holdings in Philip Morris International were worth $4,567,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GQG Partners LLC acquired a new stake in Philip Morris International during the 2nd quarter worth approximately $8,220,008,000. Bank of America Corp DE purchased a new position in shares of Philip Morris International in the 2nd quarter valued at approximately $3,075,267,000. Capital International Investors increased its holdings in shares of Philip Morris International by 13.7% in the fourth quarter. Capital International Investors now owns 101,377,875 shares of the company’s stock valued at $16,262,967,000 after purchasing an additional 12,227,004 shares during the period. Capital Research Global Investors increased its holdings in shares of Philip Morris International by 25.3% in the fourth quarter. Capital Research Global Investors now owns 54,559,706 shares of the company’s stock valued at $8,751,407,000 after purchasing an additional 11,013,173 shares during the period. Finally, Legal & General Group Plc purchased a new stake in shares of Philip Morris International during the second quarter worth approximately $1,316,151,000. Hedge funds and other institutional investors own 78.63% of the company’s stock.

Key Headlines Impacting Philip Morris International

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: Higher 2026 earnings outlook: Philip Morris raised its 2026 adjusted diluted EPS forecast to $8.35-$8.50, with the increase attributed to currency tailwinds rather than a change to its underlying operational outlook. The guidance supports investor confidence and is above the company’s previous expectations. Philip Morris Raises 2026 Earnings Guidance Amid Currency Tailwinds
• Positive Sentiment: ZYN portfolio expansion: PMI’s U.S. business is broadening ZYN with new 1.5 mg and 8 mg strengths, the higher-moisture ZYN ULTRA line, additional flavors and formats, and more pouches per can. The expanded range could attract more legal-age adult nicotine consumers and support volume growth. PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
• Positive Sentiment: Regulatory support for nicotine pouches: FDA authorization for 11 ZYN products, including higher-strength ZYN ULTRA offerings, strengthens PMI’s position in the fast-growing U.S. nicotine-pouch market and provides a foundation for scaling production after substantial manufacturing investments. FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
• Neutral Sentiment: Execution remains important: The ZYN rollout is strategically favorable, but the earnings benefit will depend on consumer adoption, manufacturing capacity and the company’s ability to convert product expansion into sustainable sales and profit growth.

Philip Morris International Trading Up 0.5%

Shares of PM stock opened at $185.71 on Thursday. The company has a market cap of $289.45 billion, a price-to-earnings ratio of 26.68, a price-to-earnings-growth ratio of 2.37 and a beta of 0.37. The stock has a 50 day simple moving average of $188.25 and a 200-day simple moving average of $178.77. Philip Morris International Inc. has a 12-month low of $142.11 and a 12-month high of $207.76.

Philip Morris International (NYSE:PM) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $2.05 by $0.15. The firm had revenue of $11.19 billion for the quarter, compared to the consensus estimate of $10.60 billion. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities analysts forecast that Philip Morris International Inc. will post 8.39 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PM has been the subject of several recent research reports. UBS Group increased their price target on Philip Morris International from $168.00 to $182.00 and gave the stock a “neutral” rating in a report on Thursday, July 2nd. Citigroup boosted their price objective on shares of Philip Morris International from $210.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Bank of America restated a “buy” rating on shares of Philip Morris International in a research report on Thursday, May 21st. Needham & Company LLC raised their target price on shares of Philip Morris International from $200.00 to $215.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Finally, Morgan Stanley lifted their target price on shares of Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Philip Morris International has an average rating of “Moderate Buy” and an average price target of $205.89.

About Philip Morris International

Philip Morris International Inc is a global tobacco and nicotine company headquartered in Stamford, Connecticut. The company develops, manufactures and markets cigarettes, smoke-free products, nicotine products and related consumer offerings in markets around the world.

Its portfolio includes internationally recognized cigarette brands such as Marlboro, Parliament, L&M and Chesterfield. PMI is also expanding beyond traditional cigarettes through heated-tobacco products, including IQOS, e-vapor products such as VEEV, and oral nicotine products including ZYN, which became part of the company’s portfolio following its acquisition of Swedish Match.

Philip Morris International was established as an independent company in 2008 after being separated from Altria Group, whose U.S.